03/13/2025
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:33 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SRPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/11/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:05 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:32 PM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:38 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
7:30 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
11:25 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s real agenda in D.C. (Ad) In this urgent exposé, you’ll discover…
How Elon and Donald Trump are quietly drawing a radical new map of America… Here’s the full story. |
12/12/2024
4:06 PM | Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:18 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
7:15 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
6:17 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:40 AM | JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
9:27 AM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
09/16/2024
7:00 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
7:05 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:51 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
4:03 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:00 AM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:50 PM | Sarepta Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024
3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
3:16 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:19 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
3:45 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
05/06/2024
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/06/2024
7:09 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
